Sjogren's syndrome: A community-based study of prevalence and impact

British Journal of Rheumatology

Volumn 37, Issue 10, 1998, Pages 1069-1076

  Thomas, E ^a   Hay, E M ^b   Hajeer, A ^a   Silman, A J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Staffordshire Rheumatology Centre   (United Kingdom)

Author keywords

Cross sectional study; Impact; Population based survey; Prevalence; Sjogren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; RHEUMATOID FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; EYE DISEASE; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SALIVATION; SCHIRMER TEST; SEX DIFFERENCE; SJOEGREN SYNDROME; ADOLESCENT; CROSS-SECTIONAL STUDY; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; RANDOMIZATION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RANDOM ALLOCATION; SJOGREN'S SYNDROME;

EID: 0031597373     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
2. Alarcón-Segovia D, Ibáñez G, Velázquez-Forero F, Hernández-Ortíz J, Gonzalez-Jiménez Y. Sjögren's syndrome in systemic lupus erythematosus. Ann Intern Med 1974;81:577-83.
3. Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:201-4.
4. Yamane K, Shome GP, Akama T, Suzuki H, Matsui Y, Kashiwagi H. Clinical features of patients with mild systemic lupus erythematosus. Scand J Rheumatol 1991;20(suppl.):397-405.
5. Andonopoulos AP, Drosos AA, Skopouli FN, Acritidis NC, Moutsopoulos HM. Secondary Sjögren's syndrome in rheumatoid arthritis. J Rheumatol 1987;14:1098-103.
6. Martinez Castro E, Olive Marques A, Bonet Llorach M, Carbonell Abello J, Cobo Valeri E, Junca Valdor S. Artritis reumatoide y sindrome de Sjogren. Referencia especial al tiempo de evolucion de la artritis reumatoide. Med Clin 1990;94:655-9.
7. Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993;32:297-301.
8. Longman LP, Higham SM, Rai K, Edgar WM, Field EA. Salivary gland hypofunction in elderly patients attending a xerostomia clinic. Gerodontology 1995; 12:67-72.
9. Forstot JZ, Forstot SL, Greer RO, Tan EM. The incidence of Sjogren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum 1982;25:156-60.
10. Whaley K, Williamson J, Wilson T et al. Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing 1972;1:197-206.
11. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-7.
12. Jacobsson LTH, Axell TE, Hansen BU et al. Dry eyes or mouth - An epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun 1989;2:521-7.
13. Zhang NZ, Shi CS, Yao QP et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol 1995;22: 659-61.
14. Hochberg MC, Schein OD, Munoz B, Anhalt G, Provost TT, West S. The prevalence of dry eye, dry mouth, autoimmunity and primary Sjögren's syndrome in the general population. Arthritis Rheum 1996;39:S66 (Abstract).
15. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. The prevalence of primary Sjogren's Syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.
16. Fox RI, Robinson CA, Curd JG, Michelson P, Bone R, Howell FV. First International Symposium on Sjögren's syndrome: Suggested criteria for classification. Scand J Rheumatol 1986;61(suppl.):28-30.
17. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjogren's syndrome in Japan. Scand J Rheumatol 1986;61(suppl.):26-7.
18. Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol 1986;61(suppl.):19-21.
19. Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol 1986; 61(suppl.):22-5.
20. Kraus A, Caballero-Uribe C, Jakez J, Villa AR, Alarcón-Segovia D. Raynaud's phenomenon in primary Sjögren's syndrome. Associations with other extraglandular manifestations. J Rheumatol 1992;19:1572-4.
21. Moutsopoulos HM, Youinou P. New developments in Sjögren's syndrome. Curr Opin Rheumatol 1991;3: 815-22.
22. Escudero D, Latorre P, Codina M, Coll-Canti J, Coll J. Central nervous system disease in Sjogren's syndrome. Ann Med Interne 1995;146:239-42.
23. Alexander EL. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993;19:869-908.
24. Alexander E. Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 1992;18:637-72.
25. Calabrese LH, Davis ME, Wilke WS. Chronic fatigue syndrome and a disorder resembling Sjögren's syndrome: preliminary report. Clin Infect Dis 1994;18(suppl. 1): S28-31.
26. Gudbjornsson B, Broman JE, Hetta J, Hallgren R. Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol 1993;32:1072-6.
27. Cartwright A. Patients and their doctors. London: Routledge and Keegan Paul, 1967.
28. Workshop participants. Manual of methods - procedures. Clin Exp Rheumatol 1989;7:213-8.
29. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Windsor: NEFR-Nelson, 1988.
30. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
31. Ware JE, Sherbourne CD. The SF-36 health status survey: I. Conceptual framework and item selection. Med Care 1992;30:473-543.
32. StataCorp. Stata statistical software: Release 5.0. College Station, TX: Stata Corporation, 1997.
33. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak associations between subjective symptoms of and objective testing for dry eyes and dry mouth: Results from a population based study. Ann Rheum Dis 1997;57:20-4.
34. Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am 1990;16:513-37.
35. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 1995;38:551-8.
36. Vitali C, Tavoni A, Neri R, Castrogiovanni P, Pasero G, Bombardieri S. Fibromyalgia features in patients with primary Sjögren's syndrome. Scand J Rheumatol 1989;18(suppl.):21-7.
37. Kelly CA, Foster H, Pal B et al. Primary Sjögren's syndrome in north east England - A longitudinal study. Br J Rheumatol 1991;30:437-42.
38. Nishikai M, Akiya K, Onoda N, Tani M, Shimizu K. 'Seronegative' Sjögren's syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol 1996; 35:471-4.
39. Maricq HR, Weinrich MC, Keil JE et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
40. Papageorgiou AC, Croft PR, Ferry S, Jayson MIV, Silman AJ. Estimating the prevalence of low back pain in the general population. Evidence from the south Manchester back pain survey. Spine 1995;20:1889-94.